|
Tenofovir
(Viread)
Articles on Tenofovir (Viread)
Meta-analysis
Finds Tenofovir and Entecavir
Are Most Effective Antiviral Drugs for Chronic Hepatitis B
8-24-2010
How Long Do Chronic Hepatitis
B Patients Need to be Treated
to Sustain HBeAg Seroconversion?
6-25-2010
Tenofovir (Viread) Effective
for Treatment of Chronic Hepatitis B Patients with Suboptimal
Response to Adefovir (Hepsera)
5-7-2010
Tenofovir
(Viread) Demonstrates High Barrier to Resistance
over 3 Years in Chronic Hepatitis B Patients
4-23-2010
Tenofovir
(Viread) Produces Long-term Response in Chronic
Hepatitis B Patients with Prior Treatment Failure
1-15-2010
Tenofovir
(Viread)
Produces Good HBV Suppression in Chronic Hepatitis B Patients
with Resistance to Adefovir (Hepsera)
11/24/09
A
Phase 2, Double-Blind, Randomized Study Comparing The Safety
of Tenofovir Disoproxil Fumarate
(TDF), Emtricitabine Plus TDF (Truvada, TVD) and
Entecavir (ETV) in Subjects with Decompensated Chronic Hepatitis
B Liver Disease
11/03/09
Tenofovir
(Viread) Regimens Are Effective and Well-tolerated
in Chronic Hepatitis B Patients with Decompensated Liver Disease
11/03/09
Entecavir
(Baraclude) and
Tenofovir (Viread) Rescue Therapy for Chronic Hepatitis
B Patients with Advanced Fibrosis and Prior Treatment Failure
11/03/09
Long-term
Follow-up Evaluation of the Efficacy and Safety of
Tenofovir Disoproxil Fumarate
(TDF) in a European Multicenter (Nucleos(t)ide
Experienced) Hepatitis B Virus HBV-infected Cohort
11/03/09
Tenofovir
(TDF) Is Effective In Lamivudine (LAM)
Resistant Chronic Hepatitis B Patients Who Harbour
rtA194T At Baseline
11/03/09
Tenofovir
Disoproxil Fumarate for patients with chronic
hepatitis B who have previously failed Lamivudine
and
Adefovir: effects of baseline sequence
mutations on virological response.
11/03/09
In
vitro susceptibility of HBV strains isolated from
HIV-HBV Coinfected patients with delayed response
to Tenofovir DF
11/03/09
Tenofovir
Disoproxil Fumarate-Containing Regimens
in Pregnancy: Report From the Antiretroviral Pregnancy
Registry
11/03/09
Three
Years of Tenofovir Disoproxil
Fumarate (TDF) Treatment in HBeAg-Positive
Patients (HBeAg+) With Chronic Hepatitis B (Study
103)
11/03/09
In
Vitro Tenofovir
Sensitivity of HBV Populations from Clinical Specimens
Containing rtA181T/V and/or rtN236T
11/03/09
Three
Years Effi cacy and Safety of Tenofovir
Disoproxil Fumarate (TDF) in Asians with
HBeAg-Positive and HBeAg-Negative Chronic Hepatitis
B
11/03/09
Three
Years of Tenofovir Disoproxil
Fumarate (TDF) Treatment in HBeAg-Negative
Patients with Chronic Hepatitis B (Study 102)
11/03/09
Resistance
Surveillance for up to 144 Weeks in HBeAg+ and HBeAg-
Hepatitis B Patients Treated with Tenofovir
DF Showed No Relationship Between Virologic
Breakthrough and Emergence of Genotypic Changes in
HBV Polymerase
11/03/09
Long-term
Studies Show Tenofovir (Viread)
Safety and Efficacy Is Sustained at 3 Years in HBeAg
Positive and Negative Hepatitis B Patients
11/03/09
Should
Entecavir (Baraclude) and Tenofovir
(Viread) Be First-line Treatment for Chronic
Hepatitis B?
6/05/09
Tenofovir
(Viread) Is Similarly Effective in Chronic
Hepatitis B Patients Regardless of Liver Cirrhosis
Status
5/08/09
Addition
of Emtricitabine (Emtriva) Does Not Improve Response
to Tenofovir (Viread) for Chronic Hepatitis
B
5/05/09
Evolution
of Viral Load and Genome Sequence in a Clinical Trial
of Tenofovir/Emtricitabine Combination Versus
Tenofovir Monotherapy for Patients with
Previous Adefovir Dipivoxil Failure
4/24/09
Tenofovir Disoproxil
Fumarate (TDF) Versus Emtricitabine Plus TDF (FTC/TDF)
for Treatment of Chronic Hepatitis B (CHB) in Patients
with Persistent Viral Replication Receiving Adefovir
Dipivoxil
4/24/09
Characteristics of HBeAg-Positive Patients
with HBsAg Loss/Seroconversion Following Treatment
with Tenofovir Disoproxil Fumarate
(TDF)
4/24/09
Safety and Efficacy of 96 Weeks of Tenofovir Disoproxil Fumarate
Therapy in Lamivudine Experienced Patients
4/24/09
Safety and Tolerability of 96 Weeks of Tenofovir
Disoproxil Fumarate (TDF) Treatment in
HBeAg Negative and Positive Patients Infected with
Chronic Hepatitis B (CHB)
4/24/09
Two Years Safety and Efficacy of Tenofovir Disoproxil Fumarate (TDF)
in Patients with HBV-Induced Cirrhosis
4/24/09
| 
